These are interesting possibilities for the therapeutic application of IFNα subtypes in HIV infection, but before such applications can be established, more research on IFNα subtypes, which we missed carrying for almost 60 years, is needed. This evidence concerns the gene IFNA2 and HIV infectious disease.